Surprisingly, in the analysis of differentially expressed genes (Figures 3A–D), we found that a range of chemokines were significantly upregulated in bladder cancer patients in the CLR-high group compared with those in the CLR-low group. This evidence concerns the gene DCLK3 and urinary bladder carcinoma.